Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets

被引：18

作者：

dos Santos Fernandes, Guilherme Felipe ^{[1
]}

Jornada, Daniela Hartmann ^{[1
]}

de Souza, Paula Carolina ^{[1
]}

Chin, Chung Man ^{[1
]}

Pavan, Fernando Rogerio ^{[1
]}

dos Santos, Jean Leandro ^{[1
]}

机构：

[1] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Araraquara, Brazil

来源：

CURRENT MEDICINAL CHEMISTRY | 2015年 / 22卷 / 27期

基金：

巴西圣保罗研究基金会;

关键词：

Antitubercular drugs; drug discovery; Mycobacterium tuberculosis; resistant tuberculosis; tuberculosis; tuberculosis targets; KILLS MYCOBACTERIUM-TUBERCULOSIS; BIOLOGICAL EVALUATION; ANTIMYCOBACTERIAL ACTIVITY; IN-VITRO; RIMINOPHENAZINE DERIVATIVES; SIDEROPHORE BIOSYNTHESIS; RESISTANT TUBERCULOSIS; MOLECULAR-PROPERTIES; INHIBITORS; DESIGN;

D O I：

10.2174/0929867322666150818103836

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Tuberculosis (TB) is an infectious disease caused by bacterium of the Mycobacterium genus, mainly by Mycobacterium tuberculosis (MTB). The World Health Organization aims to substantially reduce the number of cases in the coming years; however, the increased number of multidrug-resistant (MDR) and extremely drug-resistant (XDR) forms of the bacterium and the lack of treatment for latent tuberculosis are challenges to be overcome. In this review, we have identified the most potent compounds described in the literature during recent years with MIC values <7 mu M, low toxicity and a high selective index. In addition, emerging targets in MTB are presented to provide new perspectives for the discovery of new antitubercular drugs. This review aims to summarize the current advances in and promote insights into antitubercular drug discovery.

引用

页码：3133 / 3161

页数：29

共 50 条

[41] Role of Mycobacteria Effectors in Phagosome Maturation Blockage and New Drug Targets Discovery
Li, Wu
Xie, Jianping
JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (10) : 2688 - 2693
[42] Drug Discovery Alliances in India-Indications, Targets, and New Chemical Entities
Differding, Edmond
CHEMMEDCHEM, 2014, 9 (01) : 43 - 60
[43] Dengue structural proteins as antiviral drug targets: Current status in the drug discovery & development
Akshatha, H. S.
Pujar, Gurubasavaraj, V
Sethu, Arun Kumar
Bhagyalalitha, Meduri
Singh, Manisha
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 221
[44] Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Boniface, Pone K.
Elizabeth, Ferreira, I
CURRENT ORGANIC SYNTHESIS, 2019, 16 (07) : 968 - 1001
[45] Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery
Chen, Haijun
Wu, Jianlei
Gao, Yu
Chen, Haiying
Zhou, Jia
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (19) : 2107 - 2114
[46] Discovery of novel drug-like antitubercular hits targeting the MEP pathway enzyme DXPS by strategic application of ligand-based virtual screening
Zhu, Di
Johannsen, Sandra
Masini, Tiziana
Simonin, Celine
Haupenthal, Jorg
Illarionov, Boris
Andreas, Anastasia
Awale, Mahendra
Gierse, Robin M.
van der Laan, Tridia
van der Vlag, Ramon
Nasti, Rita
Poizat, Mael
Buhler, Eric
Reiling, Norbert
Mueller, Rolf
Fischer, Markus
Reymond, Jean-Louis
Hirsch, Anna K. H.
CHEMICAL SCIENCE, 2022, 13 (36) : 10686 - 10698
[47] Advances in microwave-assisted synthesis and the impact of novel drug discovery
Berrino, Emanuela
Supuran, Claudiu T.
EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (09) : 861 - 873
[48] Advances in Drug Discovery and Development for Pediatric Tuberculosis
Hoagland, Daniel
Zhao, Ying
Lee, Richard E.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (06) : 481 - 497
[49] Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease
Beltran-Hortelano, Ivan
Alcolea, Veronica
Font, Maria
Perez-Silanes, Silvia
BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 58
[50] Advances and Progress in Chagas Disease Drug Discovery
Ferreira, Leonardo G.
de Oliveira, Marcelo T.
Andricopulo, Adriano D.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (20) : 2290 - 2302

← 1 2 3 4 5 →